Clinical outcome of combination of vancomycin and ceftaroline versus vancomycin monotherapy for treatment of methicillin resistant Staphylococcus aureus bloodstream infection

Abstract Background The role of combination therapies for serious methicillin-resistant Staphylococcus aureus (MRSA) infections is widely debated. Methods This retrospective cohort study included adults with MRSA bacteraemia treated between January 1, 2013, to December 31, 2022. Patients receiving c...

Full description

Bibliographic Details
Published in:BMC Infectious Diseases
Main Authors: Rami Waked, Leslie Coats, Adriana Rosato, Christina F. Yen, Emily Wood, Daniel J. Diekema, Kristina E. Rokas, Nicholas J. Mercuro
Format: Article
Language:English
Published: BMC 2024-10-01
Subjects:
Staphylococcus aureus
MRSA
Bacteraemia
Vancomycin
Ceftaroline
Endocarditis
Online Access:https://doi.org/10.1186/s12879-024-10107-7

Internet

https://doi.org/10.1186/s12879-024-10107-7

Similar Items